table_1_Solute Carrier Family 30 Member 8 Gene 807C/T Polymorphism and Type 2 Diabetes Mellitus in the Chinese Population: A Meta-Analysis Including 6,942 Subjects.DOCX
Although solute carrier family 30 (zinc transporter) member 8 (SLC30A8) gene 807C/T polymorphism is associated with an increased risk of type 2 diabetes mellitus (T2DM) risk, there remains some inconsistency between individual studies.
ObjectiveThe aim of the study is to explore the relationship between SLC30A8 gene 807C/T polymorphism and T2DM in the Chinese population.
MethodsThe current meta-analysis compiles and analyzes the data of 6,942 participants from 10 independent studies. Either a fixed or random-effects model was adopted to evaluate the pooled odds ratio (ORs) and the corresponding 95% confidence interval (95% CI).
ResultsA significant association between SLC30A8 gene 807C/T polymorphism and T2DM was found in the Chinese population under allelic (OR: 0.85, 95% CI: 0.80–0.91, P = 7.42 × 10−7), recessive (OR: 0.52, 95% CI: 0.38–0.72, P = 8.49 × 10−5), dominant (OR: 2.40, 95% CI: 1.68–3.41, P = 1.30 × 10−6), homozygous (OR: 0.52, 95% CI: 0.40–0.67, P = 2.90 × 10−7), heterozygous (OR: 0.79, 95% CI: 0.71–0.88, P = 1.63 × 10−5), and additive genetic models (OR: 0.73, 95% CI: 0.64–0.83, P = 7.05 × 10−7).
ConclusionSLC30A8 gene 807C/T polymorphism was significantly associated with an increased T2DM risk in the Chinese population. Therefore, individuals of Chinese descent with the C allele of SLC30A8 gene 807C/T polymorphism may be more susceptible to developing T2DM, while individuals with the T allele may be protected against T2DM.
History
References
- https://doi.org//10.2337/db07-1583
- https://doi.org//10.2337/db07-0761
- https://doi.org//10.1242/jcs.03164
- https://doi.org//10.3969/j.issn.1006-6187.2016.01.003
- https://doi.org//10.3969/j.issn.1007-9572.2011.12.006
- https://doi.org//10.2307/2528036
- https://doi.org//10.1016/0197-2456(86)90046-2
- https://doi.org//10.1136/bmj.315.7109.629
- https://doi.org//10.3969/j.issn.1671-7171.2011.01.007
- https://doi.org//10.1007/s00228-010-0882-6
- https://doi.org//10.3969/j.issn.2095-4344.2013.31.006
- https://doi.org//10.3969/j.issn.0258-4646.2015.06.004
- https://doi.org//10.3969/j.issn.1000-0952.2014.07.046
- https://doi.org//10.13241/j.cnki.pmb.2011.12.038
- https://doi.org//10.3969/j.issn.1005-9202.2015.04.013
- https://doi.org//10.1186/1471-2350-11-81
- https://doi.org//10.2337/diab.44.11.1249
- https://doi.org//10.1007/s00125-008-0955-6
- https://doi.org//10.1007/s00109-007-0295-x
- https://doi.org//10.2337/diabetes.53.9.2330
- https://doi.org//10.1007/s10534-005-3687-9
- https://doi.org//10.3746/pnf.2017.22.1.1
- https://doi.org//10.1017/S0007114517000174
- https://doi.org//10.1126/science.1142364
- https://doi.org//10.1111/1753-0407.12025
- https://doi.org//10.12659/MSM.894052
- https://doi.org//10.1007/s12020-016-0870-4
- https://doi.org//10.3389/fendo.2017.00303
- https://doi.org//10.18632/oncotarget.18720
- https://doi.org//10.1007/s13410-017-0560-7